Meningiomas associated with subdural hematomas: A systematic review of clinical features and outcomes.
World Neurosurg 2021;
158:e465-e475. [PMID:
34763104 DOI:
10.1016/j.wneu.2021.11.001]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2021] [Revised: 10/30/2021] [Accepted: 11/01/2021] [Indexed: 11/21/2022]
Abstract
BACKGROUND
Meningiomas associated with subdural hematomas (SDH) are exceedingly rare. As such, the clinical features, optimal medical and surgical management, and outcomes of treatment for these lesions remain unknown.
METHODS
We performed a systematic review of the Pubmed and SCOPUS databases for case reports and case series on patients with presumptive clinical or definitive diagnoses of meningiomas presenting with a subdural hematoma on CT scan or MRI. Data on demographics, clinical manifestations, surgical management, adjuvant treatment, and outcome on last follow-up were collected.
RESULTS
A total of 59 cases met the inclusion criteria, including one described in the current study. The mean age of patients was 62 years (range 5 - 85 years), with a slight female predilection (1.3:1). The most common clinical symptom and sign were headache and focal weakness, respectively. All except two cases underwent surgery - either done singly or staged - for evacuation of hematoma and/or excision of tumor. Treatment for meningiomas associated with SDH was associated with a mortality rate of 12% (6/51) at a median follow up of 3 months. Complete neurologic recovery was reported in 71% of patients.
CONCLUSION
Subdural hematomas are rare presenting manifestations of intracranial meningiomas. Current management is largely surgical for immediate relief of mass effect and oncologic control. Most patients survived with complete neurologic recovery.
Collapse